Released this weekend............. Hopefully, DNDN won't go back to $5. http://www.independent.co.uk/life-s...h-news/cancer-shock-breakthrough-1710727.html
First of all, thanks to Wilburbear for the post above. Second, another way to "play" the news is with the relevant biotech company, http://finance.yahoo.com/q?s=MEDX Ipilimumab is one of a class of drugs called monoclonal antibodies, which stimulate the body's own immune system to fight disease. The experimental treatment is being developed by Bristol-Myers Squibb and Medarex, a US biotech company.